Submissions

Author Guidelines

Guideline Policy

Emerging Trends in Medical Science & Biomedical Advances considers manuscripts prepared in accordance with the guidelines established by the International Committee of Medical Journal Editors (ICMJE) for ethical publishing practices. Authors are strongly encouraged to review and adhere to these guidelines to ensure the integrity, transparency, and quality of scholarly work.

These standards include recommendations for manuscript preparation, authorship criteria, conflict of interest disclosures, clinical trial registration, ethical approval, and patient consent.

General Guidelines for Manuscript Preparation

Conflict of Interest Form: Every submission must include a completed ICMJE Conflict of Interest Form.

Blinded Manuscript: The main manuscript must be anonymized, removing author names, institutional affiliations, and acknowledgments for double-blind peer review.

Title Page: Submit separately with author details, affiliations, ORCID IDs, email addresses, acknowledgments, funding sources, and corresponding author information.

Author Metadata: Provide accurate details of all authors during submission.

Supplementary Documents (as applicable):

• Authorship declaration form
• Patient consent to publication form (if applicable)
• Institutional Review Board (IRB) / Ethics Committee approval certificate
• Trial registration number (for RCTs)
• Permissions for copyrighted material

Note: Submissions not complying with these requirements may be returned for correction before review.

Downloads

• Instructions to the Authors
• Authorship Declaration Form
• Consent to Publish Form
• ICMJE Conflict of Interest Form
• Title Page Template
• Reporting Guidelines

Emerging Trends in Medical Science & Biomedical Advances strongly encourages adherence to recognized reporting standards:

1. CONSORT – Randomized Controlled Trials
2. STROBE – Observational Studies
3. PRISMA – Systematic Reviews & Meta-Analyses
4. STARD – Diagnostic Accuracy Studies
5. CARE – Case Reports
6. Completed checklists must be uploaded as supplementary files.

Manuscript Preparation
Title Page

Must include:

• Article Title (concise, informative)
• Author details (names, affiliations, ORCID IDs, emails)
• Corresponding Author details
• Funding sources & acknowledgments
• Conflict of Interest statement
• IRB approval number (if applicable)
• Trial registration number (for RCTs)
• Patient consent statement (if applicable)

Abstract

Structured abstracts are required for most submissions:

Original Research Articles: Background, Methods, Results, Conclusion (with 3–5 MeSH keywords).

Systematic Reviews/Meta-Analyses: Background, Methods, Results, Conclusion + Trial Registration Number.

Case Reports: Background, Case Presentation, Conclusion (3–5 keywords).

Other Types: Provide an unstructured abstract + keywords.

Introduction

Clearly explain the scientific background, rationale, and research objective. Avoid presenting results here.

Methods

Provide sufficient detail for reproducibility, including:

• Study design, setting, and timeframe
• Participant inclusion/exclusion criteria
• Ethical approval (IRB/IEC) and informed consent
• Details of drugs, chemicals, or equipment (with manufacturer info in parentheses)
• Data collection procedures and analysis methods
• Software and statistical techniques used (with version numbers)
• Trial registration (if applicable)

Results

Present findings clearly with tables, figures, and text:

• Begin with primary outcomes, followed by secondary outcomes
• Avoid redundancy between text, tables, and figures
• Report both absolute numbers and statistical measures (CIs, effect sizes)

Discussion & Conclusion

Summarize key findings and interpret in light of existing biomedical literature

Discuss strengths, limitations, and implications for clinical/medical practice

Suggest directions for future research

Provide a concise conclusion reflecting the study’s significance

References

Emerging Trends in Medical Science & Biomedical Advances follows Vancouver style (ICMJE guidelines).

References numbered consecutively in order of appearance

Use square brackets [ ] for in-text citations

List up to 6 authors, then use et al.

Avoid predatory journals as references

Examples:

Smith J, Doe P, Lee K. Advances in regenerative medicine. J Biomed Res. 2020;34(2):150–8.

Brown R, et al. Cancer immunotherapy: progress and challenges. Nat Med. 2019;25:45–56.

Tables & Figures

Tables: Number consecutively (Table 1, Table 2), self-explanatory, editable text only.

Figures: High-resolution TIFF/JPEG; include scale markers, consistent labeling, and legends.

Patient-identifiable data must be anonymized with consent.

Units of Measurement

Use SI units throughout.

Blood pressure: mmHg

Temperature: °C

Drugs: Use generic names with dose and route of administration

Abbreviations & Symbols

Avoid in title/abstract

Define at first mention

Use only standard abbreviations

Types of Manuscripts

Original Research Articles

Systematic & Narrative Reviews

Case Reports & Case Series

Brief Reports

Letters to the Editor

Innovations & Techniques (new diagnostic/therapeutic approaches)

Quality Improvement Projects

Manuscript Submission

Submit via the journal’s website: https://etmsba.com/index.php/home/about/submissions
Max individual file size: 4MB.

Authorship Criteria

Substantial contribution, drafting/revising, and final approval.
Ghost or honorary authorship is strictly prohibited.

Copyright

Authors retain copyright and grant Emerging Trends in Medical Science & Biomedical Advances first publication rights. Published under CC BY-NC-SA 4.0 license.

Plagiarism Policy

Manuscripts are screened for plagiarism. Violations are handled per COPE guidelines.

Archiving Policy

Emerging Trends in Medical Science & Biomedical Advances uses LOCKSS for digital preservation, ensuring permanent accessibility.

Post-Publication Dispersion

Authors are encouraged to share published work on repositories, academic networks, or institutional websites, with proper citation.

Privacy Statement

Author and reviewer information will be used only for editorial and publication purposes. No data will be shared with third parties.